Bouslah Zoubeir, Mahjoub Rahma, Allagui Zeineb, Dabboussi Malek, Zouaoui Manel, Bibi Amina
Laboratoire de biologie clinique, Institut National « Zouheir Kallel » de nutrition et de technologie alimentaire, Tunis, Tunisie, Faculté de médecine, Université de Tunis-El Manar, Tunis, Tunisie.
Laboratoire de biologie clinique, Institut National « Zouheir Kallel » de nutrition et de technologie alimentaire, Tunis, Tunisie, Faculté de pharmacie, Université de Monastir, Monastir, Tunisie.
Ann Biol Clin (Paris). 2020 Feb 1;78(1):47-53. doi: 10.1684/abc.2019.1512.
Rapid and accurate identification of pathogens involved in urinary tract infections helps to guide antimicrobial therapy. Chromogenic agars provide presumptive identification directly from primary isolation media. They have been intended to make the bacterial isolation and identification process easier and faster. Our study aimed to compare the performance and the cost of the CPS ID3® and the Uriselect4® chromogenic agars with the conventional method for the isolation and identification of urinary tract infections bacteria. We included 301 urinary samples in a prospective study conducted in May 2018 in the clinical laboratory of the National institute of nutrition and food technology of Tunis. Isolates from routine media were identified using API® system while isolates from chromogenic media were directly identified by colony color with reference to the manufacturer's recommendations. Chromogenic media yielded more pure positive cultures and allowed better isolation of Escherichia coli, Klebsiella pneumoniae, Citrobacter koseri, Morganella morganii and Streptococcus agalactiae. Sensitivity and specificity of the presumptive identification of most commonly isolated uropathogens were higher with the Uriselect4® medium than with the CPS ID3® medium. Chromogenic media yielded the identification of pathogenic organisms 24 hours sooner than the conventional method in approximately 63 % of cases with the CPS ID3® medium and in 77.7% of cases with the Uriselect4® medium. Chromogenic media allowed a much better isolation of bacteria commonly involved in urinary tract infections with a quick, easy and accurate presumptive identification especially with the Uriselect4® medium.
快速准确地鉴定出引起尿路感染的病原体有助于指导抗菌治疗。显色培养基可直接从初代分离培养基进行初步鉴定。其目的是使细菌分离和鉴定过程更简便、快速。我们的研究旨在比较CPS ID3®和Uriselect4®显色培养基与传统方法在分离和鉴定尿路感染细菌方面的性能及成本。在突尼斯国家营养与食品技术研究所临床实验室于2018年5月进行的一项前瞻性研究中,我们纳入了301份尿液样本。使用API®系统鉴定来自常规培养基的分离株,而来自显色培养基的分离株则参照制造商的建议通过菌落颜色直接鉴定。显色培养基产生了更多的纯阳性培养物,并且能更好地分离出大肠埃希菌、肺炎克雷伯菌、科氏柠檬酸杆菌、摩根摩根菌和无乳链球菌。对于大多数常见的尿路致病菌,Uriselect4®培养基初步鉴定的敏感性和特异性高于CPS ID3®培养基。在大约63%使用CPS ID3®培养基的病例和77.7%使用Uriselect4®培养基的病例中,显色培养基比传统方法能提前24小时鉴定出致病生物。显色培养基能更好地分离出通常引起尿路感染的细菌,且能进行快速、简便和准确的初步鉴定,尤其是使用Uriselect4®培养基时。